Neurocrine Biosciences, Inc. (NBIX) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Neurocrine Biosciences, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
29.49
Moderate
WeakModerateStrong
P/B Ratio
4.34
Strong
WeakModerateStrong
Earnings Yield
3.39%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
14.71%
Moderate
WeakModerateStrong
Operating Margin
21.64%
Strong
WeakModerateStrong
Net Profit Margin
16.73%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
21.45%
Strong
WeakModerateStrong
Net Income Growth
40.23%
Strong
WeakModerateStrong
EPS Growth
41.47%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
3.39
Strong
WeakModerateStrong
Quick Ratio
3.30
Strong
WeakModerateStrong
Asset Turnover
0.62x
Moderate
WeakModerateStrong
Inventory Turnover
0.76x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
5.31%
Strong
WeakModerateStrong
EV / Free Cash Flow
18.45x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.45x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.139
Strong
WeakModerateStrong
Return on Invested Capital
10.80%
Weak
WeakModerateStrong
Cash Conversion Cycle
-163.87 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for NBIX.
View Financial Statements